Differential effects of protein kinase C inhibitors on chemokine production in human synovial fibroblasts

British Journal of Pharmacology

Volumn 117, Issue 6, 1996, Pages 1245-1253

  Jordan, Nicola J ^a   Watson, Malcolm L ^a   Yoshimura, Teizo ^b   Westwick, John ^a  

^a University of Bath   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bisindolylmaleimide; Chelerythrine chloride; Chemokine; GF 109203X; Interleukin 1 ; Protein kinase C inhibitors; Ro 31 8220; Staurosporine; Synovial fibroblasts; Tumour necrosis factor

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CHELERYTHRINE; CHEMOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBROBLAST; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; INFLAMMATORY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

EID: 0029926253     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16722.x     Document Type: Article

References (47)

1. BACON, K.B., WATSON, M.L., WESTWIC, K. J. & CAMP, R.D.R. (1990). Migration and calcium mobilisation in human lymphocytes and PMNs induced by hrIL-1α, hrIL-1β; and hrNAF/IL-8. In Molecular unit Cellular Biology of Cytokines. ed. Oppenheim, J.J., Powanda, M.C., Kluger, M.J. & Dinarello, C.A. pp. 253-258. New York: Wiley-Liss.
2. BÉDARD, P.A. & GOLDS, E.E. (1993). Cytokine-induced expression of mRNAs for chemotactic factors in human synovial cells and fibroblasts. J. Cell. Physiol., 154, 433-441.
3. BIT, R.A., DAVIES, P.D., ELLIOTT, L.H., HARRIS, W., HILL, C.H., KEECH, E., KUMAR, H., LAWTON, G. MAW, A., NIXON, J.S., VESEY, D.R., WADSWORTH, J. & WILKINSON, S.E. (1993). Inhibitors of protein kinase C 3. Potent and highly selective bisindolylmaleimides by conformational restriction. J. Med. Chem., 36, 21-29.
4. BRADSHAW, D. HILL, C.H., NIXON, J.S. & WILKINSON, S.E. (1993). Therapeutic potential of protein kinase C inhibitors. Agents Actions, 38, 135-147.
5. BRENNAN, F.M., ZACHARIAE, C.O.C., CHANTRY, D. LARSEN, C.G., TURNER, M., MAINI, R.N., MATSUSHIMA, K. & FELDMANN, M. (1990). Detection of interleukin-8 (IL-8) biological activity in synovial fluids from patients with rheumatoid arthritis and production of IL-8 mRNA by isolated synovial cells. Eur. J. Immunol., 20, 2141.
6. BROWN, Z., STRIETER, R.M., CHENSUE, S.W., CESKA, M., LINDLEY, I., NEILD, G.H., KUNKEL, S.L. & WESTWICK, J. (1991). Cytokine-activated human mesangial cells generate the neutrophil chemoattractant, interleukin 8. Kidney Int., 40, 86-90.
7. CESKA, M., EFFENBERGER, F., PEICHI, P & PURSCH, E, (1989). Purification and characterisation of monoclonal and polyclonal antibodies to neutrophil activation peptide (NAP-1). The development of highly sensitive ELISA methods for the determination of NAP-1 and anti-NAP-1 antibodies. Cytokine, 1, 136.
8. CHOMCZYNSKI, P & SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
9. DAVIES, P.D., ELLIOT, L.H., HARRIS, W., HILL, C.H., HURST, S.A., KEECH, K., HARI KUMAR, M.K., LAWTON, G., NIXON, J.S. & WILKINSON, S.K. (1992). Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity. J. Med. Chem., 35, 994-1001.
10. DAYER, J.-M., KRANE, S.M., RUSSELL, R.G.G. & ROBINSON, D.R. (1976). Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc. Natl. Acad. Sci. U.S.A., 73, 945-949.
11. DEKKER, L.V. & PARKER, P.J. (1994). Protein kinase C-a question of specificity. Trends Biol. Sci., 19, 73-77.
12. DEMARCO, D. KUNKEL, S.L., STRIETER, R.M., BASHA, M. & ZURIER, R.B. (1991). Interleukin-1 induced gene expression of neutrophil activating protein (interleukin-8) and monocyte chemotactic peptide in human synovial cells. Biochem. Biophys. Res. Commun., 174, 411-416.
13. DIAZ-MECO, M.T., BERRA, E., MUNICIO, M.M., SANZ, K., KOZANO, J., DOMINGUEZ, I., DIAZ-GOLPE, V., LAIN DE LERA, M.T., ALCAMI, J., PAYA, C.V., ARENZANA-SEISDEDOS, F., VIRELIZIER, J.L. & MOSCAT, J. (1993). A dominant negative protein kinase C zeta blocks NFkB activation. Mol. Cell. Biol., 13, 4770-4775.
14. GUY, G.R., CHUA, S.P., WONG, N.S., NG, S.B. & TAN, Y.H. (1991). Interleukin 1 and tumour necrosis factor activate common multiple protein kinases in human fibroblasts. J. Biol. Chem., 266, 14343-14352.
15. HA, K-S. & EXTON, J.H. (1993). Differential translocation of protein kinase C isozymes by thrombin and platelet derived growth factor. A possible function for phosphatidylcholine-derived diacylglycerol. J. Biol. Chem., 268, 10534-10539.
16. HERBERT, J.M., AUGEREAU, J.M., GLEYE, J. & MAFFRAND, J.P. (1990). Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun., 172, 993-999.
17. ISON, A.J., JOHNSON, M.S., MACEWAN, D.J., SIMPSON, J., CLEGG, R.A., CONNOR, K. & MITCHELL, R. (1993). Biochemical characterisation of an apparently novel isoform of protein kinase C in pituitary. Biochem. Soc. Trans., 21, 386s.
18. JOHANNES, F.J., PRESTLE, J., EIS, S., OBERHAGEMANN, P. & PFIZENMAIER, K. (1994). PKCμ is a novel, atypical member of the protein kinase C family. J. Biol. Chem., 269, 6140-6148.
19. JORDAN, N.J., WATSON, M.L. & WESTWICK, J. (1995). The protein phosphatase inhibitor calyculin A stimulates chemokine production by human synovial cells. Biochem. J., 311, 89-95.
20. KAMEYOSHI, Y., DORSCHNER, A., MALLET, A.I. CHRISTOPHERS, E. & SCHRÖDER, J.-M. (1992). Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med., 176, 587-592.
21. KOCH, A.E., KUNKEL, S.L., HARLOW, L.A., JOHNSON, B., EVANOFF, H.L., HAINES, G.K., BURDICK, M.D., POPE, R.M. & STRIETER, R.M. (1992). Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest., 90, 772-779.
22. LINDLFY, I.J.D., WESTWICK, J. & KUNKEL, S.L. (1993a). The Chemokines: Biology of the Inflammatory Peptide Supergene Family IIII Advances in Experimental Medicine and Biology, Vol 351, pp. 1-223. New York: Plenum.
23. LINDLEY, I.J.D., WESTWICK, J. & KUNKEL, S.L. (1993b). Nomenclature announcement - the chemokines. Immunol. Today, 14, 24.
24. LOMBARDINI, J.B. (1995). Paradoxical stimulatory effect of the kinase inhibitor chelerythrine on the phosphorylation of a ∼ 20K M(r) protein present in the mitochondrial fraction of rat retina. Brain Res., 673, 194-198.
25. MARTINY-BARON, G., KAZANIFTZ, M.G., MISCHAK, H., BLUMBERG, P.M., KOCHS, G., HUG, H., MARMÉ, D. & SCHÄCHTELE, C. (1993). Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J. Biol. Chem., 268, 9194-9197.
26. MUIKADA, N., MAHE, Y. & MATSUSHIMA, K. (1990). Cooperative interaction of nuclear factor-kB- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8-gene by pro-inflammatory cytokines. J. Biol. Chem., 265, 21128-21133.
27. PALMER, D.G., HOGG, N. & REVELL, P.A. (1986). Lymphocytes, polymorphonuclear leukocytes, macrophages and platelets in synovium involved in rheumatoid arthritis. A study with monoclonal antibodies. Pathology, 18, 431-437.
28. PLEASS, R.D. & WESTWICK, J. (1990). Modulation of IL-8 generation in the pre-monocytic cell line, U937. Br J. Pharmacol., 101, 530P.
29. RATHANASWAMI, P., HACHICHA, M., SADICK, M., SCHALL, T.J. & MCCOLL, S.R. (1993). Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J. Biol. Chem., 268, 5834-5839.
30. ROSOFF, P.M., SAVAGF, N. & DINARELLO, C.A. (1988). Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism. Cell, 54, 73-81.
31. SAKLATVALA, J. & GUESDON, F. (1992). Interleukin 1 and tumor necrosis factor signal transduction mechanisms: Potential targets for pharmacological control of inflammation. J. Rheumatol., 19, 65-69.
32. SCHALL, T.J., BACON, K., TOY, K.J. & GOEDDEL, D.V. (1990). Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature, 347, 669-671.
33. SCHALL, T., LU, L.H., GILLETT, N. & AMENTO, E.P. (1991). RANTES/SIS cytokine gene expression in rheumatoid synovium as analyzed by in situ hybridization. Arthritis Rheum., 34, S117.
34. STRIETER, R., PHAN, S., SHOWELL, R., REMICK, D., LYNCH, J., GENORD, M., RAIFORD, C., ESKANDARI, M., MARKS, R. & KUNKEL, S. (1989). Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J. Biol. Chem., 264, 10621-10626.
35. TAYLOR, D.J., EVANSON, J.M. & WOOLLEY, D.E. (1990). Contrasting effects of the protein kinase C inhibitor, staurosporine, on cytokine and phorbol ester stimulation of fructose 2.6-bisphosphate and prostaglandin E production by fibroblasts in vitro. Biochem. J., 269, 573-577.
36. TOULLEC, D., PIANETTI, P., COSTE, H., BELLEVERGUE, P., GRANDPERRET, T., AJAKANE, M., BAUDET, V., BOISSIN, P., BOURSIER, E., LORIOLLE, F., DUHAMEL, I., CHARON, D. & KIRILOVSKY, J. (1991). The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem., 266, 15771-15781.
37. UEDA, A., OKUDA, K., OHNO, S., SHIRAI, A., IGARASHI, T., MATSUNAGA, K., FUKUSHIMA, J., KAWAMOTO, S., ISHIGATSUBO, Y. & OKUBO, T. (1994). NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol., 153, 2052-2063.
38. VILLIGER, P.M., TERKELTAUB, R. & LOTZ, M. (1992). Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocyytes. J. Immunol., 149, 722-727.
39. VON STEBUT, E., AMON, U., HERBERT, J.M. & WOLFF, H.H. (1994). Investigations with the selective PKC inhibitor chelerythrine on human basophils. Agents Actions, 41 No. S1, C56-C57.
40. WATSON, M.L., WESTWICK, J., FINCHAM, N.J. & CAMP, R.D.R. (1988). Elevation of PMN cytosolic free calcium and locomotion stimulated by novel peptides from IL-1-treated human synovial cell cultures. Biochem. Biophys. Res. Commun., 155, 1154-1160.
41. WAYS, D.K., COOKE, P.P., WEBSTER, C. & PARKER, P.J. (1992). Effect of phorbol esters on protein kinase C-zeta. J. Biol. Chem., 267, 4799-4805.
42. WILKINSON, S.E. & HALLAM, T.J. (1994). Protein kinase C: is its pivotal role in cellular activation over-stated? Trends Pharmacol. Sci., 15, 53-57.
43. WILKINSON, S.E., PARKER, P.J. & NIXON, J.S. (1993). Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem. J., 294, 335-337.
44. YOSHIMURA, T., MATSUSHIMA, K., TANAKA, S., ROBINSON, E.A., APPELLA, E., OPPENHEIM, J.J. & LEONARD, E.J. (1987). Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defensecytokines. Proc. Natl. Acad. Sci. U.S.A., 84, 9233-9237.
45. YOSHIMURA, T., ROBINSON, E.A., TANAKA, S., APPELLA, E., KURATSU, J-I. & LEONARD, E.J. (1989). Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med., 169, 1449-1459.
46. YOSHIMURA, T., TAKEYA, M., TAKAHASHI, K., KURATSU, J.-I. & LEONARD, E.J. (1991). Production and characterisation of mouse monoclonal antibodies against human monocyte chemoattractant protein-1. J. Immunol., 147, 2229-2233.
47. ZHANG, Q.-Y., HAMMERBERG, C., BALDASSARE, J.J., HENDERSON, P.A., BURNS, D., CESKA, M., VOORHEES, J.J. & FISHER, G.J. (1992). Retinoic acid and phorbol ester synergistically upregulate IL-8 expression and specifically modulate protein kinase C-epsilon in human skin fibroblasts. J. Immunol., 149, 1402-1408.